- Home
- BRSP vs PHAR Comparison
BRSP vs PHAR Comparison
Compare BRSP & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRSP
- PHAR
- Stock Information
- Founded
- BRSP 2017
- PHAR 1988
- Country
- BRSP United States
- PHAR Netherlands
- Employees
- BRSP N/A
- PHAR N/A
- Industry
- BRSP Real Estate Investment Trusts
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- BRSP Real Estate
- PHAR Health Care
- Exchange
- BRSP Nasdaq
- PHAR Nasdaq
- Market Cap
- BRSP 561.8M
- PHAR 587.5M
- IPO Year
- BRSP 2018
- PHAR N/A
- Fundamental
- Price
- BRSP $5.28
- PHAR $9.32
- Analyst Decision
- BRSP Buy
- PHAR Strong Buy
- Analyst Count
- BRSP 5
- PHAR 3
- Target Price
- BRSP $6.88
- PHAR $30.00
- AVG Volume (30 Days)
- BRSP 573.9K
- PHAR 2.8K
- Earning Date
- BRSP 04-29-2025
- PHAR 05-08-2025
- Dividend Yield
- BRSP 11.92%
- PHAR N/A
- EPS Growth
- BRSP N/A
- PHAR N/A
- EPS
- BRSP N/A
- PHAR N/A
- Revenue
- BRSP $340,600,000.00
- PHAR $320,708,000.00
- Revenue This Year
- BRSP N/A
- PHAR $12.39
- Revenue Next Year
- BRSP $29.66
- PHAR $9.84
- P/E Ratio
- BRSP N/A
- PHAR N/A
- Revenue Growth
- BRSP N/A
- PHAR 24.13
- 52 Week Low
- BRSP $4.16
- PHAR $6.65
- 52 Week High
- BRSP $6.71
- PHAR $11.07
- Technical
- Relative Strength Index (RSI)
- BRSP 58.89
- PHAR 67.69
- Support Level
- BRSP $5.16
- PHAR $9.54
- Resistance Level
- BRSP $5.44
- PHAR $10.28
- Average True Range (ATR)
- BRSP 0.15
- PHAR 0.28
- MACD
- BRSP 0.08
- PHAR 0.15
- Stochastic Oscillator
- BRSP 86.87
- PHAR 86.17
About BRSP BrightSpire Capital Inc.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.